Surface barriers
- Walls and moat. Structural barriers that keep the invaders out.
- Intact skin and mucous membranes (mucosae), plus their secretions, such as mucus or tears. The secretions are the moat.
Pick a section. Each one opens with a picture, then gives the full detail underneath.
Picture the body as a medieval castle under attack.
Surface barriers are the skin and the mucous membranes, along with their secretions. This first line is highly effective. Mucous membranes line every body cavity that opens to the exterior: the digestive, respiratory, urinary and reproductive tracts. Intact mucosae form a mechanical barrier inside the body similar to the skin's, preventing the entry of pathogens. Find the number on the body, then read what guards that spot.
Mucus is listed both ways: slide 4 calls it a physical barrier, while slide 12 and the textbook list mucin with the protective chemicals.
When the wall is breached: the surface barriers are quite effective, but everyday nicks and cuts break them, for example when you brush your teeth or shave. Microorganisms then invade deeper tissues, and that triggers the internal second line of defense, which protects the deeper tissues.
Phagocytes (phago = eat) are central to innate defense. They are white blood cells that ingest and digest intruders. Pathogens that get through the skin or mucosae into the underlying connective tissue are confronted by them.
The phagocyte uses receptors to recognize and adhere to the carbohydrate "signature" of a pathogen (or to debris). It must adhere before it can ingest.
The phagocyte engulfs the particle much the way an amoeba ingests a food particle. Receptors on its flowing cytoplasmic extensions (pseudopodia, or pseudopods) bind to the particle. The particle is then pulled inside, enclosed within a membrane-lined vesicle called a phagosome (phagocytic vesicle).
The phagosome fuses with a lysosome, which carries acid hydrolase enzymes. Together they form a phagolysosome.
Neutrophils and macrophages generally kill their prey by acidifying the phagolysosome and digesting its contents with lysosomal enzymes. Toxic compounds and lysosomal enzymes destroy the pathogen.
Indigestible and residual material is sometimes removed by exocytosis.
Phagocytic attempts are not always successful. To ingest a pathogen, the phagocyte must first adhere to it by recognizing certain carbohydrates on its surface. Many bacteria have an external capsule that conceals this carbohydrate signature and makes them too slippery to bind, so they elude capture.
Opsonins (antibodies or complement proteins) coat the pathogen and give the phagocyte's receptors "handles" to bind, making it more adhesive. Any pathogen can be coated. The process is called opsonization ("to make tasty"), and it greatly accelerates phagocytosis.
Some pathogens, such as the tuberculosis bacillus (Mycobacterium tuberculosis) and certain parasites, are resistant to the acidified lysosomal enzymes. They are not killed and can even multiply inside the phagolysosome.
Helper T cells release chemicals that stimulate the macrophage. This activates additional enzymes that produce a lethal respiratory burst: the secretion of cell-killing chemicals. It kills by:
Normal digestion acidifies the phagolysosome. The burst then raises its pH.
Sometimes phagocytes are unable to ingest their targets.
The phagocytes secrete hydrolytic enzymes and other toxic chemicals into the extracellular fluid instead.
Whether they kill ingested or extracellular targets, neutrophils rapidly destroy themselves in the process. Macrophages are more robust and survive to kill another day.
Neutrophils also use defensins to kill by piercing the pathogen's membrane.
Slides: macrophages develop from monocytes.
Textbook: only free macrophages do. Fixed macrophages are not derived from monocytes. They arise early in embryonic development, from a structure called the yolk sac.
Also: the slides list alveolar macrophages under both free and fixed macrophages. The textbook names stellate macrophages in the liver as its example of fixed macrophages.
NK cells "police" the body in blood and lymph.
A cell's "self" surface proteins (class I MHC) inhibit NK cell attack.
A cell that lacks them is contacted directly and made to undergo apoptosis.
Three stages, in order.
Inflammatory chemicals are released into the extracellular fluid.
Arterioles dilate and capillaries become leaky.
Phagocytes are mobilized: neutrophils first, macrophages follow.
Injured cells release leukocytosis-inducing factors. Neutrophils enter the blood from red bone marrow, and within a few hours the blood neutrophil count rises four- to fivefold (your slides: 5x in hours). This increase in white blood cells is characteristic of inflammation.
Phagocytes cling to the inner walls (margins) of the capillaries and postcapillary venules. Inflamed endothelial cells sprout cell adhesion molecules (CAMs) into the vessel lumen that signal "this is the place". Neutrophils bind them briefly, which makes them slow and roll along the wall while inflammatory chemicals activate them. Activated neutrophils sprout their own CAMs and bind the endothelial cells tightly, getting an initial foothold.
Under continued chemical signaling, neutrophils flatten and squeeze between the endothelial cells of the capillary walls, moving out into the interstitial spaces. The capillary wall is the endothelium plus its basement membrane.
Inflammatory chemicals diffusing from the inflamed site act as homing devices, or chemotactic agents. Neutrophils and, later, other white blood cells undergo positive chemotaxis: they migrate up the gradient to the site of injury.
Virus enters the cell and replicates. The viral nucleic acid gets in and new viruses are made. Host cell 1 is infected by the virus.
Interferon genes switch on in the DNA of the infected cell's nucleus, and mRNA for interferon is made.
The cell produces interferon molecules and releases them. Host cell 1 makes interferon but is killed by the virus.
Interferon binds a receptor on host cell 2 and stimulates it to turn on genes for antiviral proteins. Antiviral mRNA is made.
Antiviral proteins block viral reproduction. Interferon has induced host cell 2 to synthesize these protective proteins.
White blood cells and macrophages are exposed to foreign substances in the body.
They secrete chemicals called pyrogens (pyro = fire).
Pyrogens act on the body's thermostat, a cluster of neurons in the hypothalamus, and raise its set point.
The hypothalamus activates its heat-promotion center, which acts through the SNS: skin blood vessels constrict, shivering begins, and BMR rises. Body temperature climbs.
The adaptive system must "meet" a specific foreign substance (antigen). That is, it must be primed by an initial exposure to it.
This priming takes precious time. It is the adaptive system's shortcoming: the innate system is always ready and able to react.
Only then can it protect the body against that substance. It has memory: a "known" antigen gets a quicker, stronger attack on subsequent exposures.
Animals that survived a serious bacterial infection had protective factors in their blood (the proteins we now call antibodies) that defend against future attacks by the same pathogen. When antibody-containing serum from the survivors was injected into animals never exposed to the pathogen, those animals were protected too.
At first antibodies were thought to be the sole artillery of the adaptive immune system. Then researchers found that injecting antibody-containing serum did not always protect the recipient from diseases the serum donor had survived. In such cases, injecting the donor's lymphocytes did provide immunity.
As a rule, small molecules are not immunogenic. They are too small and simple to be immunogenic by themselves.
The small molecule links up with one of the body's own proteins (a protein carrier).
The adaptive immune system may recognize the combination as foreign and mount an attack that is harmful rather than protective. The immune system attacks the hapten-bearing self-proteins.
Slides (the haptens slide): by itself, a hapten is immunogenic but not reactive. Combined with a protein, it becomes reactive.
Textbook: unless attached to protein carriers, haptens have reactivity but not immunogenicity. They must combine with a body protein before becoming immunogenic. The slide before it also says haptens are too small and simple to be immunogenic by themselves.
Most antigens have several different antigenic determinants. Here three different types of antibodies react with different antigenic determinants on the same antigen molecule.
A huge variety of protein molecules dot the external surfaces of all your cells. Your self-antigens are not foreign or antigenic to you.
The same self-antigens are strongly antigenic to other individuals. This is the basis of transfusion reactions and graft rejection.
Each MHC protein has a deep groove that holds a peptide: either a self-antigen or a foreign antigen.
T lymphocytes can only bind antigens that are presented (displayed to them) on MHC proteins.
Two distinct populations of lymphocytes, plus antigen-presenting cells.
Both B and T lymphocyte precursors originate in red bone marrow.
Precursors destined to become T cells migrate (in blood) to the thymus and mature there. B cells mature in the bone marrow. During maturation lymphocytes develop immunocompetence and self-tolerance.
Immunocompetent but still naive lymphocytes leave the thymus and bone marrow. They "seed" the secondary lymphoid organs and circulate through blood and lymph.
Antigen encounter and activation: when a lymphocyte's antigen receptors bind its antigen, that lymphocyte can be activated.
Proliferation and differentiation: activated lymphocytes proliferate (multiply) and then differentiate into effector cells and memory cells.
Slides: about 25,000 genes encode a billion different antigen receptors.
Textbook: each body cell contains only about 20,000 genes that code for all the proteins the cell must make.
At the body's frontiers, dendritic cells internalize antigens by phagocytosis. Their long, wispy extensions make them very efficient antigen catchers.
They then enter nearby lymphatics to get to a lymph node.
In the lymph node they present the antigens to T cells.
When a B cell encounters its antigen (its complementary antigen), that antigen provokes the humoral immune response, in which antibodies specific for that antigen are made.
Antigen binds to a receptor on a specific B lymphocyte. B lymphocytes with noncomplementary receptors remain inactive.
The activated B cells proliferate to form a clone.
Most cells of the clone become plasma cells (effector B cells), which secrete antibody molecules.
The other clone cells become memory B cells, primed to respond to the same antigen.
The five major immunoglobulin classes are IgG, IgA, IgM, IgE and IgD, designated on the basis of the C regions in their heavy chains. Remember the word GAMED to recall the five Ig types. Each class has different characteristics, biological roles and locations in the body. Key characteristics are in bold.
IgE antibodies coat the surface of the parasitic worm, marking it for destruction.
When eosinophils encounter antibody-coated worms, they bind to the exposed stems of the IgE.
This triggers the eosinophils to release the toxic contents of their large cytoplasmic granules all over their prey (your slides: degranulation of hydrolytic enzymes and other toxic chemicals).
Slides: antibodies do not invade solid tissue unless a lesion is present.
Textbook: antibodies never invade solid tissues unless inflammation is present.
Proteases (protein-digesting enzymes) degrade cytoplasmic proteins as part of their natural recycling.
A random sample of the resulting protein fragments is transported into the endoplasmic reticulum (your slides: the rough ER, RER).
Inside the ER, the peptides bind to newly synthesized class I MHC proteins.
Transport vesicles export the "loaded" class I MHC proteins to the cell surface.
The cell engulfs an exogenous antigen. Proteases break it down (your slides: the antigens are hydrolyzed) inside a phagolysosome.
Vesicles from the ER (your slides: RER-generated vesicles) containing class II MHC proteins fuse with the phagolysosome.
The antigen fragments bind to the groove of the class II MHC proteins.
The vesicle is exported to the cell surface, where the class II MHC protein displays its prize for CD4 cells to recognize.
One slide: class II MHC is a signal to destroy all cells displaying that antigen on MHC I.
Textbook, and a later slide: class II MHC with foreign antigen signals that help is needed: "Help me mount a defense against it." The "kill any cell that displays it" message belongs to class I MHC on an APC.
The dendritic cell engulfs a dying virus-infected or tumor cell. It can also import antigens through temporary gap junctions with infected cells, rather than engulf.
It frees the antigens from the phagosome, digests them, and transports fragments into the rough ER.
The antigens bind complementary MHC I in the rough ER.
It displays the engulfed cell's endogenous proteins on both class I and class II MHCs. The MHC I-antigen complex comes in a vesicle from the rough ER. MHC II comes in a vesicle from the phagolysosome.
A dendritic cell engulfs an exogenous antigen, processes it, and displays its fragments on a class II MHC protein.
2a The CD4 T cell recognizes the antigen-MHC complex. Both the TCR and the CD4 protein bind to the antigen-MHC complex. 2b Co-stimulatory molecules bind their receptors.
Activated CD4 T cells proliferate (clone) and become memory and effector cells.
Clonal selection of T cells involves simultaneous recognition of self and nonself. Activation of a CD4 cell is shown here; activation of CD8 cells is similar.
Secreted by many cells (your slides: by a virus-infected cell, in protection of adjacent cells). Have antiviral effects. Activate NK cells.
Secreted by lymphocytes (your slides: from B and T cells). Activates macrophages. Stimulates synthesis and expression of more class I and II MHC proteins. Promotes differentiation of TH cells into TH1.
Secreted by activated macrophages. Promotes inflammation and T cell activation. Causes fever (acts as a pyrogen that resets the thermostat of the hypothalamus).
Secreted by TH cells. Stimulates T and B cell proliferation, TReg cell development, and NK cell activation. Your slides: stimulates TC proliferation and differentiation.
Secreted by TH cells (your slides: by some TH cells). Promotes differentiation to TH2, B cell activation (your slides: completes B cell co-stimulation), and IgE antibody secretion (your slides: switches antibody production to IgE).
Secreted by TH cells (your slides: by some TH cells) and mast cells. Activates eosinophils (your slides: attracts and activates them) and promotes IgA antibody secretion (your slides: causes plasma cells to secrete IgA antibodies).
A potent pro-inflammatory cytokine. Links innate and adaptive immune responses. Attracts lymphocytes and macrophages. Blockers of this cytokine are used to treat some autoimmune diseases and severe COVID-19. Your slides: promotes inflammation, and comes from various white blood cells as well as non-immune cells.
Secreted by macrophages, TH and TReg cells. Inhibits macrophages and dendritic cells. Turns down the cellular and innate immune response.
Secreted by dendritic cells and macrophages. Stimulates TC and NK cell activity. Promotes TH1 differentiation.
Secreted by TH17 cells. Important in innate and adaptive immunity and in recruiting neutrophils. Involved in inflammation in many autoimmune diseases.
A generic term for a number of cytokines that suppress the immune system, for example TGF-β and IL-10.
A suppressor factor similar to IL-10. Stimulates TReg and TH17 cell development.
Produced by lymphocytes and in large amounts by macrophages. Promote inflammation. Enhance phagocyte chemotaxis and nonspecific killing. Slow tumor growth by selectively damaging tumor blood vessels. Promote cell death by apoptosis.
The TH cell binds with the self-nonself complexes of a B cell that has encountered its antigen and is displaying it on MHC II on its surface.
The TH cell releases interleukins (IL-4 and other cytokines) as co-stimulatory signals to complete B cell activation.
The TH cell binds the dendritic cell.
The TH cell stimulates the dendritic cell to express co-stimulatory molecules.
The dendritic cell can now activate the CD8 cell, with the help of interleukin 2 secreted by the TH cell. The CD8 cell becomes a TC cell after activation.
The CD8 cell is bound to the APC by the MHC I-antigen complex to its TCR, stabilized by CD8 to MHC I.
The TH cell binds the APC via its TCR to the MHC II-antigen complex, stabilized by CD4 to MHC II.
The TH cell secretes cytokines including IL-2. Dendritic cells express and extrude the co-stimulatory molecule CD80. CD80 binds the CD8 cell's co-stimulatory receptor, CD28.
The TC cell proliferates and differentiates.
Which subset develops during TH cell differentiation depends on the type of antigen, the site at which it is encountered, and the cytokine exposure of the differentiating TH cell.
The TC identifies foreign antigens on MHC I proteins and binds tightly to the target cell.
The TC releases perforin and granzyme molecules from its granules by exocytosis.
Perforin molecules insert into the target cell membrane, polymerize, and form transmembrane pores (cylindrical holes) similar to those produced by complement activation.
Granzymes enter the target cell via the pores. Once inside, granzymes activate enzymes that trigger apoptosis.
The TC detaches and searches for another prey.
Lymphocyte that matures in bone marrow. Its progeny (clone members) form plasma cells and memory cells. Its B cell receptor is a membrane-bound antibody.
Antibody-producing "machine"; produces huge numbers of antibodies. An effector B cell.
An effector CD4 T cell central to both humoral and cellular immunity. It stimulates production of cytotoxic T cells and plasma cells, activates macrophages, and acts both directly and indirectly by releasing cytokines.
An effector CD8 T cell that kills invaded body cells and cancer cells.
An effector CD4 T cell that slows or stops activity of the immune system. Important in controlling autoimmune diseases; several different kinds.
Descendant of an activated B cell or any class of activated T cell; generated during the initial immune response. May exist in the body for years, enabling it to respond quickly and efficiently to subsequent encounters with the same antigen.
Any of several cell types (dendritic cell, macrophage, B cell) that engulfs and digests antigens that it encounters, then presents parts of them on its plasma membrane (bound to an MHC protein) for recognition by T cells bearing receptors for the same antigen. This function, antigen presentation, is essential for activation of T cells.
Substance capable of provoking an immune response. Typically a large, complex molecule (for example a protein or modified protein) not normally present in the body.
Protein produced by a B cell or by a plasma cell. Antibodies produced by plasma cells are released into body fluids (blood, lymph, saliva, mucus, etc.), where they attach to antigens. This causes complement activation, neutralization, precipitation or agglutination, which "marks" the antigens for destruction by phagocytes or complement.
Released by TC cells. Perforins create large pores in the target cell's membrane, allowing entry of apoptosis-inducing granzymes.
Group of bloodborne proteins activated after binding to antibody-covered antigens or certain molecules on the surface of microorganisms; enhances the inflammatory response and lyses some microorganisms.
Small proteins that act as chemical messengers between various parts of the immune system.
HIV's GP120 binds the CD4 receptor. The envelope and the cell membrane fuse, and HIV enters.
HIV is uncoated, releasing its RNA genomes and viral proteins (the enzymes reverse transcriptase, integrase and protease).
The viral enzyme reverse transcriptase makes a DNA copy (cDNA) from the viral RNA.
Integrase transports the cDNA into the nucleus and incorporates it into the host genome as a provirus.
If the host cell is inactive (a memory cell), HIV remains latent, hidden from the immune system and from drugs. If the host cell is active, the provirus may be replicated, or transcribed and translated with the TH cell's enzymes.
If the provirus is expressed, viral genomes and proteins are assembled. Protease cleaves the proteins to activate them.
New virions bud out of the host, taking an envelope with them from the host's plasma membrane. They search for new TH cells to infect.
The virus carries two identical + strands of RNA and reverse transcriptase inside a capsid and an envelope. The retrovirus enters by fusion between its attachment spikes and the host cell receptors.
Uncoating releases the two viral RNA strands and the viral enzymes reverse transcriptase, integrase and protease.
Reverse transcriptase copies viral RNA to produce double-stranded DNA.
The new viral DNA is transported into the host cell's nucleus, where it is integrated into a host cell chromosome as a provirus by viral integrase. The provirus may be replicated when the host cell replicates.
Transcription of the provirus may also occur, producing RNA for new retrovirus genomes and RNA that encodes the retrovirus capsid, enzymes and envelope proteins.
Viral proteins are processed by viral protease. Some of the viral proteins are moved to the host plasma membrane.
The mature retrovirus leaves the host cell, acquiring an envelope and attachment spikes as it buds out.
Antibodies are made against a foreign antigen.
If the determinants of the foreign antigen resemble those on a self-antigen, the antibodies can cross-react with the self-antigen.
Systematically destroys joints. Your slides: the trigger is thought to be bacterial or viral antigens resembling GAGs in the joints.
Impairs communication between nerves and skeletal muscles. Your slides: caused by antibodies that destroy nicotinic receptors at the neuromuscular junction.
Destroys the myelin of the white matter of the brain and spinal cord (CNS myelin). Your slides: antibodies against Epstein-Barr virus (EBV) erroneously bind CAMs (cell adhesion molecules) in oligodendrocytes.
Prompts the thyroid gland to produce excessive amounts of thyroxine (hyperthyroidism). Your slides: antibodies against follicular cells mimic TSH.
Destroys pancreatic beta cells, resulting in a deficit of insulin and inability to use carbohydrates. Your slides: genetics and pathogen exposure are possible triggers, and TC cells target the beta cells with an assist from TH and B cells.
A systemic disease that particularly affects the kidneys, heart, lungs and skin. Your slides: triggers include genes and environment (UV light, drugs, pathogens and failed apoptosis). The immune dysregulation includes overreactive B and T cells and massive secretion of interferons alpha and beta.
Damages the kidney's filtration membrane and severely impairs renal function. Your slides: inflammation of the filtration membrane is caused by (1) direct immune attack on the membrane, or (2) indirect damage in clearing antigens or immune complexes trapped in the membrane.
Sensitization stage. Antigen (allergen) invades the body. This first meeting produces no symptoms.
Plasma cells produce large amounts of class IgE antibodies against the allergen.
IgE antibodies attach by their stems to mast cells in body tissues (and to circulating basophils). The mast cell now carries fixed IgE antibodies, and its granules contain histamine.
Subsequent (secondary) responses. More of the same antigen invades the body.
The antigen combines with (binds and cross-links) the IgE attached to mast cells and basophils. This triggers degranulation and the release of histamine and other chemicals.
Histamine causes blood vessels to dilate and become leaky, which promotes edema. It stimulates secretion of large amounts of mucus, and it causes smooth muscles to contract. If the respiratory system is the site of antigen entry, asthma may ensue.
Step 1, adherence. The capsule hides the carbohydrate signature the phagocyte needs to bind. Opsonins (antibodies or complement proteins) coat the bacterium and give the phagocyte handles to grab.
Lines 1 and 2 are innate (nonspecific). Line 3 is adaptive (specific): it attacks particular foreign substances, has memory, and takes longer to react.
Mucus loaded with dust and bacteria would no longer be swept toward the mouth, so it would not be kept out of the lower respiratory passages.
Helper T cells stimulate the macrophage to produce a respiratory burst: free radicals, oxidizing chemicals, and a rise in pH and osmolarity that activates protein-digesting enzymes.
The macrophage. Neutrophils destroy themselves in the process of killing, while macrophages are robust and survive. The late-arriving macrophages replace the dying neutrophils and continue with debris removal before repair.
The MHC proteins on the first cell inhibit NK cell attack. The cell lacking this "self" protein is treated as abnormal: the NK cell contacts it directly and induces apoptosis. NK cells are not phagocytic.
Inflammatory chemicals dilate arterioles, causing hyperemia: redness and heat. They also make capillaries leaky, so exudate seeps into the tissue: swelling (edema). The swelling presses on nerve endings: pain. Pain also comes from bacterial toxins and from prostaglandins and kinins.
Leukocytosis: neutrophils are released from bone marrow into the blood. Margination: they cling to the capillary wall using CAMs. Diapedesis: they flatten and squeeze out between endothelial cells. Chemotaxis: they follow the chemical trail to the injury.
No. The infected cell is killed by the virus. Its interferon binds receptors on neighboring cells, which then make antiviral proteins that block viral reproduction. The protection is not virus-specific.
C3, which splits into C3a and C3b. C3b opsonizes pathogens and triggers insertion of the membrane attack complex (C5b–C9), which lyses the cell. C3a (with C5a) amplifies inflammation by stimulating histamine release.
Fever is systemic; inflammation is localized. White blood cells and macrophages exposed to foreign substances secrete pyrogens, which raise the hypothalamic set point.
It must first "meet" the specific foreign substance: it has to be primed by an initial exposure to that antigen, and priming takes time. Only then can it protect the body against that substance.
Adaptive defenses involve B and T lymphocytes, are specific (recognize and target particular antigens), are slow to mobilize, have memory (a stronger reaction to later encounters with the same antigen), and are systemic (not restricted to the initial infection site). Your slides stress three: specific, systemic, memory.
The free virus is an extracellular target, so humoral immunity: antibodies circulating in body fluids bind it, inactivate it temporarily and mark it for destruction by phagocytes or complement. The infected cell is a cellular target, so cellular immunity: living cells, the T lymphocytes, act directly by killing the infected cell or indirectly by releasing chemicals.
A complete antigen has both immunogenicity (it stimulates specific lymphocytes to proliferate) and reactivity (it reacts with the activated lymphocytes and the antibodies released). A hapten, or incomplete antigen, is a small molecule that is not immunogenic by itself. It must link up with one of the body's own proteins before the immune system responds to it.
Slides and textbook differ. Textbook: alone, a hapten has reactivity but not immunogenicity. One slide: alone, a hapten is immunogenic but not reactive, and becomes reactive when combined with a protein.
Acting as an antigen depends on both size and complexity. A large protein has hundreds of chemically different antigenic determinants, which gives it high immunogenicity and reactivity. A plastic is large but simple: many identical, regularly repeating units, so it has little or no immunogenicity.
Self-antigens on the cell surface, including the glycoproteins called MHC proteins, mark a cell as self. They are not antigenic to you, but they are strongly antigenic to other individuals, which is the basis of transfusion reactions and graft rejection. It is unlikely that any two people except identical twins have the same MHC proteins.
The appearance of its receptors. When B or T cells become immunocompetent, they display a unique type of receptor on their surface, and all of a cell's receptors are the same, so it is committed to one antigenic determinant.
B cells mature in the red bone marrow and T cells in the thymus (the primary lymphoid organs). Maturation gives them immunocompetence (able to recognize one specific antigen) and self-tolerance (relatively unresponsive to self-antigens).
The antigen does the selecting. When it binds the particular lymphocyte that has a receptor for it, it selects that lymphocyte for further development. Once activated, that cell proliferates into a clone of identical cells: mostly effector cells, plus a few memory cells.
It passes positive selection (it can recognize self-MHC) but fails negative selection, so it is eliminated by apoptosis. This clonal deletion is the basis of self-tolerance: it keeps T cells from attacking the body's own cells, which would cause autoimmune disorders.
Dendritic cells, macrophages and B lymphocytes. Dendritic cells are the most effective antigen presenter. B cells do not activate naive T cells: they present antigen to a helper T cell to obtain help in their own activation.
By somatic recombination. Lymphocyte stem cells hold a few hundred gene segments (a "Lego set"), and as each lymphocyte becomes immunocompetent the segments are shuffled and combined in different ways. The newly assembled genes are expressed as the cell's surface receptors.
The immune system has already been primed to the antigen, and sensitized memory cells are already "on alert". The primary response needs a lag of 3 to 6 days while the few B cells specific for the antigen proliferate and their offspring differentiate into plasma cells. In a secondary response a new army of plasma cells is being generated within hours, and the antibody titer peaks within 2 to 3 days instead of about 10.
IgG is the most abundant in plasma (75–85% of circulating antibodies). IgM is the first class secreted by plasma cells during the primary response. Secretory IgA (the dimer) is the one found in body secretions. IgE binds by its stem end to mast cells or basophils.
PLAN: precipitation, lysis (by complement), agglutination and neutralization. Neutralization, agglutination and precipitation inactivate the antigen and enhance phagocytosis. Complement activation leads to cell lysis and also enhances phagocytosis and inflammation.
The baby has naturally acquired passive immunity: ready-made antibodies, no challenge to its own B cells, no memory, and the protection ends when the antibodies degrade. The vaccinated child has artificially acquired active immunity: its own B cells met the antigen and made antibodies. Active immunity establishes immunological memory; passive immunity never does.
The two antigen-binding sites are at the tips of the two arms, where the variable (V) regions of a heavy and a light chain combine. The constant (C) regions that form the stem determine the class and are the effector regions.
A vaccine "primes" the immune response by providing a first encounter with the antigen, so a later real encounter gets the faster, stronger secondary response. Its weakened antigens provide functional antigenic determinants that are both immunogenic and reactive, and it spares us most of the symptoms of the disease that would otherwise occur during the primary response.
Exogenous antigens: fragments of phagocytized extracellular pathogens. Naive CD4 cells and helper T cells recognize them. Class II MHC is displayed only by APCs: dendritic cells, macrophages and B cells.
The T cell becomes tolerant to that antigen and is unable to respond: anergy. The two-signal requirement is a safeguard. Without it, class I MHC proteins on healthy body cells, which display peptides from within the cell, could activate cytotoxic T cells and cause widespread damage to healthy cells.
The helper T cell. It mobilizes both arms: it co-stimulates B cells to complete their activation, it enables dendritic cells to activate CD8 cells into cytotoxic T cells (and supplies IL-2), and its cytokines activate macrophages and recruit other immune cells. Without helper T cells there is no adaptive immune response.
It identifies foreign antigen on the cell's class I MHC and binds tightly. It releases perforin and granzyme molecules from its granules by exocytosis. Perforin inserts into the target membrane and forms pores. Granzymes enter through the pores and activate enzymes that trigger apoptosis. The T cell detaches and searches for another prey.
Cytotoxic T cells look for foreign antigen displayed on class I MHC proteins. NK cells do not: they search for other signs of abnormality, including the lack of class I MHC. Class I MHC proteins inhibit NK cell attack, so NK cells stalk abnormal cells that cytotoxic T cells cannot "see".
By cross-presentation. The dendritic cell engulfs dying virus-infected or tumor cells (or imports antigens through temporary gap junctions with infected cells) and displays those cells' endogenous antigens on both its class I and class II MHC proteins.
It destroys helper T cells, the cells that direct the whole adaptive response, so both branches of adaptive immunity are depressed. Its provirus can sit latent inside inactive (memory) cells, hidden from the immune system and from drugs. And its reverse transcriptase makes frequent errors, giving HIV a relatively high mutation rate and the ability to develop drug resistance.
On a later encounter, the allergen binds and cross-links the IgE antibodies already attached to the surface of the mast cells (and basophils). That triggers degranulation and the release of histamine and other chemicals. The first contact only sensitizes: IgE is made and attaches to the mast cells, with no symptoms.
Type I (immediate): begins within seconds, lasts about half an hour, caused by IgE on mast cells and basophils. Types II (cytotoxic) and III (immune-complex) are subacute: onset 1–3 hours, lasting 10–15 hours, caused by IgG and IgM. Type IV (delayed): 1–3 days, caused by T cells rather than antibodies.
Weakly self-reactive lymphocytes survive negative selection. They can be set off when (1) foreign antigens resemble self-antigens, so antibodies against the foreign antigen cross-react with self (as in rheumatic fever after a streptococcal infection), or (2) new self-antigens appear, from gene mutations, from hapten attachment or infectious damage, or from normally hidden antigens released by trauma.
The mechanism is essentially the same, but the allergen typically enters the blood directly, and mast cells and basophils are enlisted throughout the body. The bronchioles constrict (and the tongue may swell), making it hard to breathe, and sudden vasodilation and fluid loss from the blood may cause circulatory collapse and death within minutes. Epinephrine is the drug of choice.
It suppresses rejection, in which NK cells, macrophages, antibodies and especially T cells destroy tissue they recognize as foreign. The cost: the suppressed immune system cannot protect the body against malignant cells and foreign invaders, so cancers and overwhelming infections remain common causes of death in transplant patients.
A comprehensive video covering both humoral and cell-mediated immunity in response to rhinovirus (common cold) infection. A concise and yet detailed summary of adaptive immunity.
Open the Pearson video1:47 skin and mucous membranes. 3:17 phagocytes. 4:29 natural killer cells. 5:16 inflammation and fever.
Where it differs from your class: the intro calls all innate defenses the "first line". Later it matches your class: barriers are the first line and the internal innate defenses the second. It shows margination, diapedesis and chemotaxis without naming them. It does not cover interferons or complement.
Open on the Crash Course site